Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Learn how value tilts steer retirement portfolio index funds toward undervalued opportunities, balancing risk while pursuing higher long-term gains.
25,656 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Synopsys, a leader in chip design software, trades below its 52-week high even as revenue grows, highlighting investo...
As Wiley (WLY) gears up for its 2026 earnings, investors should focus on segment growth, margin trajectory, and the c...
Investors are buzzing about a big quarter from Micron. In micron's explosive earnings report:, the company posted a p...
Looking for steady, dependable income from your investments? This guide shows how to locate an industrial stock with ...
As vernova's next earnings report approaches, traders and long-term investors weigh margin trends, project momentum, ...
A wave of new analyst calls on Thursday centers on Alcon, First Solar, Five Below, Joby Aviation, Spotify, Trade Desk...
Coinbase just delivered fantastic news for investors by expanding beyond crypto into stocks and ETFs. This article br...
In stock market today, march, Grab surprised investors with a substantial buyback and a bold Foodpanda expansion. Thi...
Is UPS stock a long-term winner? This guide breaks down the turnaround story, real numbers, and a clear plan for eval...
Two entertainment giants, Netflix and Disney, are navigating a fast-changing landscape. This analysis breaks down rec...
Anthropic's IPO signals more than one company going public. It underscores a rising demand for AI compute, potentiall...